How to Use : Wet your body and face with water
General safety considerations from published sources include potential injection site reactions for injectable formats, an initial adjustment period where some individuals report temporary effects, and individual response variation based on numerous factors
The strongest signals were seen in epigenetic measures linked to inflammation, brain, heart, blood, kidney, liver and metabolic health, suggesting that the drug may influence aging-related biology across multiple body systems
There is a physiological rationale for supplementation with electrolytes and ketone esters, but a lack of clinical studies documenting their effect
Kidney problems include kidney stones, acute kidney injury, chronic kidney disease (CKD), and end-stage renal failure
Semaglutide is currently the most prominent approved option in this class: Ozempic (semaglutide injection) licensed for type 2 diabetes management Wegovy (semaglutide 2.4 mg injection) licensed specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity